{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:07:03Z","timestamp":1789456023292,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05502-4","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T16:15:32Z","timestamp":1776269732000},"page":"4997-5011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MRI risk stratification in metabolic dysfunction\u2013associated steatotic liver disease (MASLD): from diffuse liver disease to focal lesions"],"prefix":"10.1007","volume":"51","author":[{"given":"Gabriela","family":"Carboni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia Henz","family":"Concatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubia","family":"Vanceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Meira","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Schuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"5502_CR1","doi-asserted-by":"publisher","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic Dysfunction\u2013Associated Steatotic Liver Disease in Adults: A Review. JAMA. 2025 Nov 10. doi:https:\/\/doi.org\/10.1001\/jama.2025.19615","DOI":"10.1001\/jama.2025.19615"},{"issue":"6","key":"5502_CR2","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"issue":"7","key":"5502_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMra2412865","volume":"393","author":"G Targher","year":"2025","unstructured":"Targher G, Valenti L, Byrne CD. Metabolic Dysfunction\u2013Associated Steatotic Liver Disease. N Engl J Med. 2025;393(7):683\u201398. doi:https:\/\/doi.org\/10.1056\/NEJMra2412865","journal-title":"N Engl J Med"},{"key":"5502_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.21037\/tgh-24-41","volume":"9","author":"J Liang","year":"2024","unstructured":"Liang J, Kim N, Yang JD. Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease. Transl Gastroenterol Hepatol. 2024;9:67\u201367. doi:https:\/\/doi.org\/10.21037\/tgh-24-41","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"2","key":"5502_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/HEP.0000000000000843","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Duarte-Rojo A, Patel K, Asrani SK, Alsawas M, Dranoff JA, et al. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81(2):672\u2013724. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000000843","journal-title":"Hepatology"},{"issue":"12","key":"5502_CR6","doi-asserted-by":"publisher","first-page":"e240221","DOI":"10.1148\/rg.240221","volume":"45","author":"EG Osta","year":"2025","unstructured":"Osta EG, Rios FS, Jaganathan S, Thomas C, Tsai E, Surabhi V, et al. Current Update on Nomenclature, Diagnosis, and Management of Metabolic Dysfunction\u2013associated Steatotic Liver Disease: Radiologists\u2019 Perspective. RadioGraphics. 2025;45(12):e240221. doi:https:\/\/doi.org\/10.1148\/rg.240221","journal-title":"RadioGraphics"},{"issue":"11","key":"5502_CR7","doi-asserted-by":"publisher","first-page":"e240048","DOI":"10.1148\/rg.240048","volume":"44","author":"S Hosseini Shabanan","year":"2024","unstructured":"Hosseini Shabanan S, Martins VF, Wolfson T, Weeks JT, Ceriani L, Behling C, et al. MASLD: What We Have Learned and Where We Need to Go\u2014A Call to Action. RadioGraphics. 2024;44(11):e240048. doi:https:\/\/doi.org\/10.1148\/rg.240048","journal-title":"Call to Action. RadioGraphics"},{"issue":"1","key":"5502_CR8","doi-asserted-by":"publisher","first-page":"100774","DOI":"10.1016\/j.aohep.2022.100774","volume":"28","author":"L Torres","year":"2023","unstructured":"Torres L, Schuch A, Longo L, Valentini BB, Galv\u00e3o GS, Luchese E, et al. New FIB-4 and NFS cutoffs to guide sequential non-invasive assessment of liver fibrosis by magnetic resonance elastography in NAFLD. Ann Hepatol. 2023;28(1):100774. doi:https:\/\/doi.org\/10.1016\/j.aohep.2022.100774","journal-title":"Ann Hepatol"},{"issue":"4","key":"5502_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","volume":"13","author":"S Singh","year":"2015","unstructured":"Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies. Clin Gastroenterol Hepatol. 2015;13(4):643\u2013654.e9. doi:https:\/\/doi.org\/10.1016\/j.cgh.2014.04.014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"5502_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diabetes Endocrinol. 2025;13(2):134\u201348. doi:https:\/\/doi.org\/10.1016\/S2213-8587(24)00318-8","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"5502_CR11","doi-asserted-by":"publisher","first-page":"101185","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli F, Della Pepa G, Sabatini S, Vidal Puig A, Gastaldelli A. Lipid metabolism in MASLD and MASH: From mechanism to the clinic. JHEP Rep. 2024;6(12):101185. doi:https:\/\/doi.org\/10.1016\/j.jhepr.2024.101185","journal-title":"JHEP Rep"},{"issue":"2","key":"5502_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2015;149(2):389\u2013397.e10. doi:https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043","journal-title":"Gastroenterology"},{"issue":"5","key":"5502_CR13","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/hep.32204","volume":"75","author":"AJ Sanyal","year":"2022","unstructured":"Sanyal AJ, Anstee QM, Trauner M, Lawitz EJ, Abdelmalek MF, Ding D, et al. Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis. Hepatology. 2022;75(5):1235\u201346. doi:https:\/\/doi.org\/10.1002\/hep.32204","journal-title":"Hepatology"},{"issue":"1","key":"5502_CR14","doi-asserted-by":"publisher","first-page":"e250026","DOI":"10.1148\/radiol.250026","volume":"317","author":"M Deng","year":"2025","unstructured":"Deng M, Li Z, Sun L, Wang H, Tang J, Liu Y, et al. Liver MRI\u2013derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study. Radiology. 2025;317(1):e250026. doi:https:\/\/doi.org\/10.1148\/radiol.250026","journal-title":"Radiology"},{"issue":"3","key":"5502_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"F Tacke","year":"2024","unstructured":"Tacke F, Horn P, Wai-Sun Wong V, Ratziu V, Bugianesi E, Francque S, et al. EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024;81(3):492\u2013542. doi:https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"issue":"7","key":"5502_CR16","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K, Abdelmalek MF, Apovian CM, Balapattabi K, Bannuru RR, Barb D, et al. Metabolic Dysfunction\u2013Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association. Diabetes Care. 2025;48(7):1057\u201382. doi:https:\/\/doi.org\/10.2337\/dci24-0094","journal-title":"Diabetes Care"},{"issue":"4","key":"5502_CR17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","volume":"165","author":"JJ Wattacheril","year":"2023","unstructured":"Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ. AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology. 2023;165(4):1080\u20138. doi:https:\/\/doi.org\/10.1053\/j.gastro.2023.06.013","journal-title":"Gastroenterology"},{"issue":"4","key":"5502_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1053\/j.gastro.2023.06.030","volume":"165","author":"G Semmler","year":"2023","unstructured":"Semmler G, Yang Z, Fritz L, K\u00f6ck F, Hofer BS, Balcar L, et al. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease. Gastroenterology. 2023;165(4):1041\u201352. doi:https:\/\/doi.org\/10.1053\/j.gastro.2023.06.030","journal-title":"Gastroenterology"},{"issue":"5","key":"5502_CR19","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797\u2013835. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"issue":"10","key":"5502_CR20","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1136\/gutjnl-2020-322976","volume":"70","author":"J Jung","year":"2021","unstructured":"Jung J, Loomba RR, Imajo K, Madamba E, Gandhi S, Bettencourt R, et al. MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis. Gut. 2021;70(10):1946\u201353. doi:https:\/\/doi.org\/10.1136\/gutjnl-2020-322976","journal-title":"Gut"},{"issue":"11","key":"5502_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.7863\/jum.2003.22.11.1155","volume":"22","author":"W Kratzer","year":"2003","unstructured":"Kratzer W, Fritz V, Mason RA, Haenle MM, Kaechele V, Roemerstein Study Group. Factors Affecting Liver Size: A Sonographic Survey of 2080 Subjects. J Ultrasound Med. 2003;22(11):1155\u201361. doi:https:\/\/doi.org\/10.7863\/jum.2003.22.11.1155","journal-title":"J Ultrasound Med"},{"key":"5502_CR22","doi-asserted-by":"publisher","first-page":"e20250052","DOI":"10.1590\/0100-3984.2025.0052-en","volume":"(58","author":"G Carboni","year":"2025","unstructured":"Carboni G, Torres L, Furlin G, Morais G, Vanceta R, Ghezzi C, et al. Quantitative MRI assessment in metabolic dysfunction associated steatotic liver disease: correlation between the MRI-PDFF and liver size. Radiol Bras. 2025;(58:e20250052en). doi:https:\/\/doi.org\/10.1590\/0100-3984.2025.0052-en","journal-title":"Radiol Bras"},{"issue":"1","key":"5502_CR23","doi-asserted-by":"publisher","first-page":"e240176","DOI":"10.1148\/rg.240176","volume":"45","author":"PJ Pickhardt","year":"2025","unstructured":"Pickhardt PJ, Lubner MG. Noninvasive Quantitative CT for Diffuse Liver Diseases: Steatosis, Iron Overload, and Fibrosis. RadioGraphics. 2025;45(1):e240176. doi:https:\/\/doi.org\/10.1148\/rg.240176","journal-title":"RadioGraphics"},{"issue":"3","key":"5502_CR24","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/HEP.0000000000000844","volume":"81","author":"RK Sterling","year":"2025","unstructured":"Sterling RK, Asrani SK, Levine D, Duarte-Rojo A, Patel K, Fiel MI, et al. AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension. Hepatology. 2025;81(3):1060\u201385. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000000844","journal-title":"Hepatology"},{"issue":"9","key":"5502_CR25","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.crad.2021.06.014","volume":"76","author":"IS Idilman","year":"2021","unstructured":"Idilman IS, Celik A, Savas B, Idilman R, Karcaaltincaba M. The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study. Clin Radiol. 2021;76(9):709. doi:10.1016\/j.crad.2021.06.014","journal-title":"Clin Radiol"},{"issue":"6","key":"5502_CR26","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00261-017-1049-z","volume":"42","author":"JK Jang","year":"2017","unstructured":"Jang JK, Jang HJ, Kim JS, Kim TK. Focal fat deposition in the liver: diagnostic challenges on imaging. Abdom Radiol. 2017;42(6):1667\u201378. doi:https:\/\/doi.org\/10.1007\/s00261-017-1049-z","journal-title":"Abdom Radiol"},{"issue":"1","key":"5502_CR27","doi-asserted-by":"publisher","first-page":"e221856","DOI":"10.1148\/radiol.221856","volume":"307","author":"SB Reeder","year":"2023","unstructured":"Reeder SB, Yokoo T, Fran\u00e7a M, Hernando D, Alberich-Bayarri \u00c1, Al\u00fastiza JM, et al. Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR. Radiology. 2023;307(1):e221856. doi:https:\/\/doi.org\/10.1148\/radiol.221856","journal-title":"Radiology"},{"issue":"2","key":"5502_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/liv.15787","volume":"44","author":"D Suresh","year":"2024","unstructured":"Suresh D, Li A, Miller MJ, Wijarnpreecha K, Chen VL. Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease. Liver Int. 2024;44(2):389\u201398. doi:https:\/\/doi.org\/10.1111\/liv.15787","journal-title":"Liver Int"},{"issue":"04","key":"5502_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1055\/s-0039-1693114","volume":"39","author":"W Moris","year":"2019","unstructured":"Moris W, Verhaegh P, Jonkers D, Deursen CV, Koek G. Hyperferritinemia in Nonalcoholic Fatty Liver Disease: Iron Accumulation or Inflammation? Semin Liver Dis. 2019;39(04):476\u201382. doi:https:\/\/doi.org\/10.1055\/s-0039-1693114","journal-title":"Semin Liver Dis"},{"issue":"9","key":"5502_CR30","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1007\/s00261-016-0736-5","volume":"41","author":"A Pirasteh","year":"2016","unstructured":"Pirasteh A, Clark HR, Sorra EA, Pedrosa I, Yokoo T. Effect of steatosis on liver signal and enhancement on multiphasic contrast-enhanced magnetic resonance imaging. Abdom Radiol. 2016;41(9):1744\u201350. doi:https:\/\/doi.org\/10.1007\/s00261-016-0736-5","journal-title":"Abdom Radiol"},{"issue":"7","key":"5502_CR31","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.14309\/ajg.0000000000002857","volume":"119","author":"C Frenette","year":"2024","unstructured":"Frenette C, Mendiratta-Lala M, Salgia R, Wong RJ, Sauer BG, Pillai A. ACG Clinical Guideline: Focal Liver Lesions. Am J Gastroenterol. 2024;119(7):1235\u201371. doi:https:\/\/doi.org\/10.14309\/ajg.0000000000002857","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"5502_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.gastro.2025.02.034","volume":"169","author":"WY Liu","year":"2025","unstructured":"Liu WY, Huang S, Ji H, Kim SU, Yip TCF, Wong GLH, et al. From \u201cBurnt-Out\u201d to \u201cBurning-Out\u201d: Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction\u2013Associated Steatotic Liver Disease From a Dynamic Perspective. Gastroenterology. 2025;169(2):326\u2013336.e4. doi:https:\/\/doi.org\/10.1053\/j.gastro.2025.02.034","journal-title":"Gastroenterology"},{"issue":"6","key":"5502_CR33","doi-asserted-by":"publisher","first-page":"e220181","DOI":"10.1148\/rg.220181","volume":"43","author":"FF Guglielmo","year":"2023","unstructured":"Guglielmo FF, Barr RG, Yokoo T, Ferraioli G, Lee JT, Dillman JR, et al. Liver Fibrosis, Fat, and Iron Evaluation with MRI and Fibrosis and Fat Evaluation with US: A Practical Guide for Radiologists. RadioGraphics. 2023;43(6):e220181. doi:https:\/\/doi.org\/10.1148\/rg.220181","journal-title":"RadioGraphics"},{"issue":"9","key":"5502_CR34","doi-asserted-by":"publisher","first-page":"e70280","DOI":"10.1111\/liv.70280","volume":"45","author":"KE Corey","year":"2025","unstructured":"Corey KE, Nakrour N, Bethea ED, Shay JE, Andersson KL, Bhan I, et al. Real-World Assessment of Liver Corrected T1 and Magnetic Resonance Elastography in Predicting Liver Disease Progression. Liver Int. 2025;45(9):e70280. doi:https:\/\/doi.org\/10.1111\/liv.70280","journal-title":"Liver Int"},{"issue":"3","key":"5502_CR35","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00261-019-02382-9","volume":"45","author":"DH Hoffman","year":"2020","unstructured":"Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Shanbhogue KP. T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol. 2020;45(3):692\u2013700. doi:https:\/\/doi.org\/10.1007\/s00261-019-02382-9","journal-title":"Abdom Radiol"},{"key":"5502_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejrad.2019.07.001","volume":"118","author":"VC Obmann","year":"2019","unstructured":"Obmann VC, Marx C, Berzigotti A, Mertineit N, Hrycyk J, Gr\u00e4ni C, et al. Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis. Eur J Radiol. 2019;118:66\u201374. doi:https:\/\/doi.org\/10.1016\/j.ejrad.2019.07.001","journal-title":"Eur J Radiol"},{"issue":"11","key":"5502_CR37","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1007\/s00261-025-04945-5","volume":"50","author":"FV De Oliveira Terzi","year":"2025","unstructured":"De Oliveira Terzi FV, Parente DB, Camargo GC, Pittella AM, Silva-Junior G, De Novaes GG, et al. MRI-derived extracellular volume to assess liver fibrosis in patients with metabolic-associated steatotic liver disease. Abdom Radiol. 2025;50(11):5223\u201331. doi:https:\/\/doi.org\/10.1007\/s00261-025-04945-5","journal-title":"Abdom Radiol"},{"issue":"5","key":"5502_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41574-023-00807-6","volume":"19","author":"L Valenti","year":"2023","unstructured":"Valenti L, Corradini E, Adams LA, Aigner E, Alqahtani S, Arrese M, et al. Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nat Rev Endocrinol. 2023;19(5):299\u2013310. doi:https:\/\/doi.org\/10.1038\/s41574-023-00807-6","journal-title":"Nat Rev Endocrinol"},{"key":"5502_CR39","doi-asserted-by":"publisher","first-page":"119053","DOI":"10.1016\/j.atherosclerosis.2024.119053","volume":"400","author":"S Iturbe-Rey","year":"2025","unstructured":"Iturbe-Rey S, Maccali C, Arrese M, Aspichueta P, Oliveira CP, Castro RE, et al. Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD). Atherosclerosis. 2025;400:119053. doi:https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.119053","journal-title":"Atherosclerosis"},{"issue":"11","key":"5502_CR40","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1007\/s00261-020-02779-x","volume":"45","author":"S Poetter-Lang","year":"2020","unstructured":"Poetter-Lang S, Bastati N, Messner A, Kristic A, Herold A, Hodge JC, et al. Quantification of liver function using gadoxetic acid-enhanced MRI. Abdom Radiol. 2020;45(11):3532\u201344. doi:https:\/\/doi.org\/10.1007\/s00261-020-02779-x","journal-title":"Abdom Radiol"},{"issue":"1","key":"5502_CR41","doi-asserted-by":"publisher","first-page":"15408","DOI":"10.1038\/srep15408","volume":"5","author":"N Verloh","year":"2015","unstructured":"Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, et al. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Sci Rep. 2015;5(1):15408. doi:https:\/\/doi.org\/10.1038\/srep15408","journal-title":"Sci Rep"},{"issue":"1","key":"5502_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s44326-024-00015-0","volume":"11","author":"M Mazzola","year":"2024","unstructured":"Mazzola M, Cannella R, Pilato G, Blandino AA, Milazzo M, Matteini F, et al. Quantitative liver MRI biomarkers: what the radiologist should know. J Med Imaging Interv Radiol. 2024;11(1):13. doi:https:\/\/doi.org\/10.1007\/s44326-024-00015-0","journal-title":"J Med Imaging Interv Radiol"},{"issue":"3","key":"5502_CR43","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/jmri.25518","volume":"45","author":"A Ba-Ssalamah","year":"2017","unstructured":"Ba-Ssalamah A, Bastati N, Wibmer A, Fragner R, Hodge JC, Trauner M, et al. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we? J Magn Reson Imaging. 2017;45(3):646\u201359. doi:https:\/\/doi.org\/10.1002\/jmri.25518","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"5502_CR44","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s00261-016-1002-6","volume":"42","author":"SK Venkatesh","year":"2017","unstructured":"Venkatesh SK, Hennedige T, Johnson GB, Hough DM, Fletcher JG. Imaging patterns and focal lesions in fatty liver: a pictorial review. Abdom Radiol. 2017;42(5):1374\u201392. doi:https:\/\/doi.org\/10.1007\/s00261-016-1002-6","journal-title":"Abdom Radiol"},{"issue":"3","key":"5502_CR45","doi-asserted-by":"publisher","first-page":"e220134","DOI":"10.1148\/rg.220134","volume":"43","author":"JR Tse","year":"2023","unstructured":"Tse JR, Felker ER, Naini BV, Shen L, Shen J, Lu DSK, et al. Hepatocellular Adenomas: Molecular Basis and Multimodality Imaging Update. RadioGraphics. 2023;43(3):e220134. doi:https:\/\/doi.org\/10.1148\/rg.220134","journal-title":"RadioGraphics"},{"issue":"1","key":"5502_CR46","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ijc.35097","volume":"156","author":"J Vaz","year":"2025","unstructured":"Vaz J, Jepsen P, Str\u00f6mberg U, Midl\u00f6v P, Eriksson B, Buchebner D, et al. Metabolic dysfunction-associated steatotic liver disease has become the most common cause of hepatocellular carcinoma in Sweden: A nationwide cohort study. Int J Cancer. 2025;156(1):40\u201351. doi:https:\/\/doi.org\/10.1002\/ijc.35097","journal-title":"Int J Cancer"},{"issue":"4","key":"5502_CR47","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","volume":"23","author":"DJH Tan","year":"2022","unstructured":"Tan DJH, Ng CH, Lin SY, Pan XH, Tay P, Lim WH, et al. Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis. Lancet Oncol. 2022;23(4):521\u201330. doi:https:\/\/doi.org\/10.1016\/S1470-2045(22)00078-X","journal-title":"Lancet Oncol"},{"issue":"6","key":"5502_CR48","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","volume":"78","author":"AG Singal","year":"2023","unstructured":"Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922\u201365. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000000466","journal-title":"Hepatology"},{"issue":"4","key":"5502_CR49","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s00330-024-10606-w","volume":"34","author":"R Cannella","year":"2024","unstructured":"Cannella R, Zins M, Brancatelli G. ESR Essentials: diagnosis of hepatocellular carcinoma\u2014practice recommendations by ESGAR. Eur Radiol. 2024;34(4):2127\u201339. doi:https:\/\/doi.org\/10.1007\/s00330-024-10606-w","journal-title":"Eur Radiol"},{"issue":"7","key":"5502_CR50","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1111\/j.1478-3231.2012.02783.x","volume":"32","author":"J Xu","year":"2012","unstructured":"Xu J, Igarashi S, Sasaki M, Matsubara T, Yoneda N, Kozaka K, et al. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int. 2012;32(7):1156\u201364. doi:https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02783.x","journal-title":"Liver Int"},{"issue":"3","key":"5502_CR51","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jhep.2023.04.025","volume":"79","author":"Jxu Liang","year":"2023","unstructured":"Liang J xu, Ampuero J, Niu H, Imajo K, Noureddin M, Behari J, et al. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography. J Hepatol. 2023;79(3):592\u2013604. doi:https:\/\/doi.org\/10.1016\/j.jhep.2023.04.025","journal-title":"J Hepatol"},{"issue":"7","key":"5502_CR52","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S2468-1253(23)00066-3","volume":"8","author":"MA Tincopa","year":"2023","unstructured":"Tincopa MA, Loomba R. Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lancet Gastroenterol Hepatol. 2023;8(7):660\u201370. doi:https:\/\/doi.org\/10.1016\/S2468-1253(23)00066-3","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"5502_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022;18(1):55\u201366. doi:https:\/\/doi.org\/10.1038\/s41574-021-00584-0","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"5502_CR54","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/jmri.29610","volume":"61","author":"C Beyer","year":"2025","unstructured":"Beyer C, Andersson A, Shumbayawonda E, Alkhouri N, Banerjee A, Pandya P, et al. Quantitative MRI for Monitoring Metabolic Dysfunction-Associated Steatotic Liver Disease: A Test\u2013Retest Repeatability Study. J Magn Reson Imaging. 2025;61(4):1947\u201355. doi:https:\/\/doi.org\/10.1002\/jmri.29610","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"5502_CR55","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","volume":"19","author":"JG Stine","year":"2021","unstructured":"Stine JG, Munaganuru N, Barnard A, Wang JL, Kaulback K, Argo CK, et al. Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2021;19(11):2274\u20132283.e5. doi:https:\/\/doi.org\/10.1016\/j.cgh.2020.08.061","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5502_CR56","doi-asserted-by":"publisher","unstructured":"Loomba R, Daniel PCYN, Wang Y, Bettencourt R, Madamba E, Siddiqi H, et al. Clinical Utility of a 50% and 30% Decline in Magnetic Resonance Imaging-Proton Density Fat Fraction in Predicting Fibrosis Improvement in Metabolic Dysfunction-associated Steatohepatitis. Clin Gastroenterol Hepatol. 2026;S1542356526000686. doi:https:\/\/doi.org\/10.1016\/j.cgh.2026.01.039","DOI":"10.1016\/j.cgh.2026.01.039"},{"key":"5502_CR57","doi-asserted-by":"publisher","unstructured":"Bansal MB, Patton H, Morgan TR, Carr RM, Dranoff JA, Allen AM. Semaglutide therapy for metabolic dysfunction\u2013associated steatohepatitis: November 2025 updates to AASLD Practice Guidance. Hepatology. 2025 Nov 7. doi:https:\/\/doi.org\/10.1097\/HEP.0000000000001608","DOI":"10.1097\/HEP.0000000000001608"},{"issue":"24","key":"5502_CR58","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2502242","volume":"392","author":"M Noureddin","year":"2025","unstructured":"Noureddin M, Rinella ME, Chalasani NP, Neff GW, Lucas KJ, Rodriguez ME, et al. Efruxifermin in Compensated Liver Cirrhosis Caused by MASH. N Engl J Med. 2025;392(24):2413\u201324. doi:https:\/\/doi.org\/10.1056\/NEJMoa2502242","journal-title":"N Engl J Med"},{"issue":"1","key":"5502_CR59","doi-asserted-by":"publisher","first-page":"e222801","DOI":"10.1148\/radiol.222801","volume":"307","author":"V Chernyak","year":"2023","unstructured":"Chernyak V, Fowler KJ, Do RKG, Kamaya A, Kono Y, Tang A, et al. LI-RADS: Looking Back, Looking Forward. Radiology. 2023;307(1):e222801. doi:https:\/\/doi.org\/10.1148\/radiol.222801","journal-title":"Radiology"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05502-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:14:24Z","timestamp":1789452864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05502-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5502"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05502-4","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}